| | 88979-61-7 Basic information More.. |
| Product Name: | BAFILOMYCIN C1 | | Synonyms: | 2-Demethyl-2-methoxy-24-methylhygrolidin;Antibiotic L-681110A1;L-681110A1;BAFILOMYCIN C1;2-Butenedioic acid (2E)-, 1-[(2R,4R,5S,6R)-tetrahydro-2-hydroxy-2-[(1S,2R,3S)-2-hydroxy-3-[(2R,3S,4E,6E,9S,10S,11R,12E,14Z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-methylbutyl]-5-methyl-6-(1-methylethyl)-2H-pyran-4-yl] ester;Bafilomycin C1, from Streptomyces griseus;Bafilomycin C-1,Bafilomycin C1;Bafilomycin C1, Vacuolar-type H+-ATPase inhibitor. | | CAS: | 88979-61-7 | | MF: | C39H60O12 | | MW: | 720.89 | | EINECS: | | | Mol File: | 88979-61-7.mol |  |
Use
Bafilomycin C1 is a member of a potent family of macrocyclic lactones. Bafilomycin C1 shares a similar mode of action and activity as its more accessible A1 analogue. Bafilomycin C1 is broadly active against bacteria, fungi, insects, nematodes and cestodes. Bafilomycin C1 has attracted interest as a potential agent for treating osteoporosis. The presence of the fumarate group provides an ideal ligand for affinity chromatography of V-ATPase.
- Bafilomycin C1
-
- $287.00
- 2026-07-16
- CAS:88979-61-7
- Purity:
- Supply Ability: 10g
|
|
88979-61-7
Recommend Suppliers |
|